Stay updated with breaking news from Biologics Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Performance Reflects Execution and Actions to Strengthen the Company's Long-Term Growth Profile First Quarter Revenues were $11.9 Billion, increasing 5% Growth Portfolio Revenues were $4.8...
Authorization based on clinical, pre-clinical and manufacturing data for Omicron-adapted bivalent vaccines Pfizer-BioNTech Omicron BA.4/BA.5 Bivalent Vaccine combines 15-g of mRNA encoding
Corporate insiders buy penny stocks & these 10 are getting purchased in December 2021.